Literature DB >> 20496642

Chemically contaminated casualties: different problems and possible solutions.

Joseph Scanlon1.   

Abstract

The initial response to mass casualty incidents is usually informal as uninjured and injured survivors and passersby assist the injured and take them to medical centers. This creates some problems, for example, most victims go to one or two hospitals and the least injured arrive first; but, on the whole, it works. However, the same response does not work when victims are contaminated, and some of the solutions that work when victims are only injured do not work when victims are contaminated. This article suggests an approach that accepts the reality of what happens-the first receiving hospital becomes contaminated--and suggests how planning can begin with that as a starting point. It stressed that current plans are based on false assumptions and that this can lead to inadequate preparation.

Mesh:

Substances:

Year:  2010        PMID: 20496642

Source DB:  PubMed          Journal:  Am J Disaster Med        ISSN: 1932-149X


  3 in total

1.  Threat of Secondary Chemical Contamination of Emergency Departments and Personnel: An Uncommon but Recurrent Problem.

Authors:  Theodore C Larson; Maureen F Orr; Erik Auf der Heide; Jennifer Wu; Sutapa Mukhopadhyay; D Kevin Horton
Journal:  Disaster Med Public Health Prep       Date:  2015-11-10       Impact factor: 1.385

2.  Evidence-based patient decontamination: an integral component of mass exposure chemical incident planning and response.

Authors:  Adam D Leary; Michael D Schwartz; Mark A Kirk; Joselito S Ignacio; Elaine B Wencil; Susan M Cibulsky
Journal:  Disaster Med Public Health Prep       Date:  2014-05-27       Impact factor: 5.556

Review 3.  Mass Casualty Decontamination for Chemical Incidents: Research Outcomes and Future Priorities.

Authors:  Samuel Collins; Thomas James; Holly Carter; Charles Symons; Felicity Southworth; Kerry Foxall; Tim Marczylo; Richard Amlôt
Journal:  Int J Environ Res Public Health       Date:  2021-03-17       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.